Condition: Mycobacterium Avium Complex Pulmonary Disease · Sponsor: Radboud University Medical Center
To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
This description comes directly from the study's public registry record.
Arthur Lemson, MSc · +31634265743 · arthur.lemson@radboudumc.nl
Wouter Hoefsloot, MSc, PhD · +31611072569 · wouter.hoefsloot@radboudumc.nl
Always discuss trial participation with your own doctor first.
| Oregon Science and Health University | Portland, Oregon, United States | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| University of Calgary | Calgary, Alberta, Canada | Recruiting |
| University Hospital Center Zagreb | Zagreb, Croatia | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Rasmus Rude Laub | Hellerup, Denmark | Recruiting |
| University Hospital Frankfurt | Frankfurt, Germany | Recruiting |
| Fukujuji Hospital | Tokyo, Japan | Recruiting |
| Radboud University Medical Center | Nijmegen, Netherlands | Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05906316